Clinical Trial Update: Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer [Phase 1]

View source ↗

Summary

Completed Phase I study assessing stereotactic body radiation therapy combined with FOLFIRINOX as neoadjuvant therapy for pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• FOLFIRINOX regimen (5-fluorouracil, leucovorin, oxaliplatin, irinotecan)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Stereotactic Body Radiation Therapy (SBRT)

Snippet

Sponsor: Emory University | Conditions: Cancer of Pancreas, Cancer of the Pancreas | Phase 1 | Status: COMPLETED